10x Genomics, Inc. Class A Common Stock (TXG) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TXG. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 17,629,266 | $676M | DECREASED |
| Vanguard | 13,112,197 | $503M | DECREASED |
| BlackRock | 10,804,070 | $414M | INCREASED |
| ARK Invest | 10,003,057 | $384M | DECREASED |
| T. Rowe Price | 5,805,961 | $223M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Adam Taich (Chief Financial Officer) | SELL | 13,754 | $898K | 2026-09-09 |
| Adam Taich (Chief Financial Officer) | SELL | 31,428 | $2M | 2026-09-09 |
| Adam Taich (Chief Financial Officer) | SELL | 1,206 | $77K | 2026-09-09 |
| John R Stuelpnagel (Director) | SELL | 6,174 | $387K | 2026-09-03 |
| John R Stuelpnagel (Director) | SELL | 6,814 | $423K | 2026-09-03 |
Full institutional holdings, insider history, and congressional trades for 10x Genomics, Inc. Class A Common Stock on SentiSense.